Literature DB >> 16036783

Role of TIMP-2 in fascia transversalis on development of inguinal hernias.

Ilker Abci1, Selcuk Bilgi, Aydin Altan.   

Abstract

The exact reason for the development of inguinal hernia has not been completely determined. However, it is known that the fascia transversalis (FT) is one of the structures preventing development of hernias. In the etiology of the inguinal hernia, disorders in collagen metabolism have been proposed, and the role of metalloproteinases in remodeling the collagen has recently been of great importance. We could not encounter any study where the role of metalloproteinase inhibitors was evaluated in inguinal hernia. We obtained samples of FT from patients with direct and indirect hernia and used an immunohistochemical method to determine tissue inhibitor of metalloproteinase-2 (TIMP-2) expression. In the study group, samples of FT were taken during the operation from 45 patients, of which 35 were indirect and 10 were direct inguinal hernias. In the control group, samples of FT from various abdominal incisions were also taken from 45 patients with no hernia and operated upon for another pathology. TIMP-2 scores of a direct inguinal hernia were significantly less than those of the control group. However, no difference has been found between the TIMP-2 scores of an indirect inguinal hernia and those of the control group. Decreased TIMP-2 scores in patients with a direct inguinal hernia, compared with both the indirect inguinal hernia group and the control group, explain the reason for the increase in matrix metalloproteinase-2 (MMP-2) that has been proposed in some studies. Therefore, it can be expressed that a decreased activity of TIMP-2 plays a role in inguinal hernia development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036783     DOI: 10.1080/08941930590956147

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  8 in total

1.  Groin hernia subtypes are associated in patients with bilateral hernias: a 14-year nationwide epidemiologic study.

Authors:  Jakob Burcharth; Kristoffer Andresen; Hans-Christian Pommergaard; Jacob Rosenberg
Journal:  Surg Endosc       Date:  2014-10-16       Impact factor: 4.584

2.  Colonic diverticulosis is associated with abdominal wall hernia.

Authors:  E Oma; L N Jorgensen; S Meisner; N A Henriksen
Journal:  Hernia       Date:  2017-03-27       Impact factor: 4.739

Review 3.  Are collagens the culprits in the development of incisional and inguinal hernia disease?

Authors:  U Klinge; M Binnebösel; P R Mertens
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

4.  Mesh materials and hernia repair.

Authors:  Santhini Elango; Sakthivel Perumalsamy; Krishnakumar Ramachandran; Ketankumar Vadodaria
Journal:  Biomedicine (Taipei)       Date:  2017-08-25

5.  Results at 3-year follow-up of totally extraperitoneal (TEP) hernia surgery with long-term resorbable mesh.

Authors:  F Ruiz-Jasbon; K Ticehurst; J Ahonen; J Norrby; P Falk; M-L Ivarsson
Journal:  Hernia       Date:  2020-01-10       Impact factor: 4.739

6.  MMPs/TIMPs and inflammatory signalling de-regulation in human incisional hernia tissues.

Authors:  Jordi Guillen-Marti; Ramon Diaz; Maria T Quiles; Manuel Lopez-Cano; Ramon Vilallonga; Pere Huguet; Santiago Ramon-y-Cajal; Albert Sanchez-Niubo; Jaume Reventós; Manel Armengol; Maria A Arbos
Journal:  J Cell Mol Med       Date:  2008-12-29       Impact factor: 5.310

7.  Inguinal hernia repair using a synthetic long-term resorbable mesh: results from a 3-year prospective safety and performance study.

Authors:  F Ruiz-Jasbon; J Norrby; M-L Ivarsson; S Björck
Journal:  Hernia       Date:  2014-04-26       Impact factor: 4.739

8.  The role of tissue inhibitor of metalloproteinases in the aetiology of inguinal and incisional hernias.

Authors:  Ugur Durukan; Orhan Agcaoglu; Emre Ozoran; Salih Nafiz Karahan; Ibrahim Ozata; Yigit Duzkoylu; Esra Pasaoglu; Acar Aren
Journal:  Int Wound J       Date:  2022-03-11       Impact factor: 3.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.